India drug panel waives local trials for generic HIV prevention shot
India's drug regulator has moved toward allowing generic lenacapavir, a twice-yearly injectable HIV prevention drug, by recommending waiver of local Phase 3 clinical trials for Dr Reddy's Laboratories and Emcure Pharmaceuticals. The…









































